For example, dasatinib is used in the activation of EphA3 via mediating role of the ABL1 protein kinase domain in lymphoblastic leukemia, and PORCN is considered suitable for the palmitoleation of mammalian Wnts to treat ovarian cancer. Here, EPHA3 is linked to acute lymphoblastic leukemia.